Report
EUR 13.72 For Business Accounts Only

BEIJING WANDONG ME reduced its risk exposure resulting in an upgrade to Slightly Positive

BEIJING WANDONG ME (CN), a company active in the Medical Equipment industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 2 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date July 9, 2021, the closing price was CNY 18.44 and its potential was estimated at CNY 19.39.
Underlying
Beijing Wandong Medical Technology (A)

Beijing Wandong Medical Equipment is engaged in the production and sale of various types of medical equipments and machineries. Through its subsidiaries, Co. is also engaged in the sale of medical-used vehicles and provision of repair services; and medical uses of third-type electronic instrument and equipment and medical-used ultrasonic instrument and related equipment. Co.'s main products include the whole series of medical-used X-ray diagnosis and treatment equipment, dental diagnosis and treatment equipment, and medical-used magnetic resonance equipment.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch